168 related articles for article (PubMed ID: 16621541)
1. 2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists.
Carling RW; Russell MG; Moore KW; Mitchinson A; Guiblin A; Smith A; Wafford KA; Marshall G; Atack JR; Street LJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3550-4. PubMed ID: 16621541
[TBL] [Abstract][Full Text] [Related]
2. Imidazo[1,2-b][1,2,4]triazines as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Jennings AS; Lewis RT; Russell MG; Hallett DJ; Street LJ; Castro JL; Atack JR; Cook SM; Lincoln R; Stanley J; Smith AJ; Reynolds DS; Sohal B; Pike A; Marshall GR; Wafford KA; Sheppard WF; Tye SJ
Bioorg Med Chem Lett; 2006 Mar; 16(6):1477-80. PubMed ID: 16386900
[TBL] [Abstract][Full Text] [Related]
3. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
[TBL] [Abstract][Full Text] [Related]
4. 2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor.
Mitchinson A; Atack JR; Blurton P; Carling RW; Castro JL; Curley KS; Russell MG; Marshall G; McKernan RM; Moore KW; Narquizian R; Smith A; Street LJ; Thompson SA; Wafford K
Bioorg Med Chem Lett; 2004 Jul; 14(13):3441-4. PubMed ID: 15177449
[TBL] [Abstract][Full Text] [Related]
5. Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
Russell MG; Carling RW; Street LJ; Hallett DJ; Goodacre S; Mezzogori E; Reader M; Cook SM; Bromidge FA; Newman R; Smith AJ; Wafford KA; Marshall GR; Reynolds DS; Dias R; Ferris P; Stanley J; Lincoln R; Tye SJ; Sheppard WF; Sohal B; Pike A; Dominguez M; Atack JR; Castro JL
J Med Chem; 2006 Feb; 49(4):1235-8. PubMed ID: 16480260
[TBL] [Abstract][Full Text] [Related]
6. Pyrazolopyridinones as functionally selective GABAA ligands.
Blackaby WP; Atack JR; Bromidge F; Lewis R; Russell MG; Smith A; Wafford K; McKernan RM; Street LJ; Castro JL
Bioorg Med Chem Lett; 2005 Nov; 15(22):4998-5002. PubMed ID: 16153832
[TBL] [Abstract][Full Text] [Related]
7. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
[TBL] [Abstract][Full Text] [Related]
8. New fluoro derivatives of the pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide system: evaluation of fluorine binding properties in the benzodiazepine site on γ-aminobutyrric acid type A (GABA(A)) receptor. Design, synthesis, biological, and molecular modeling investigation.
Guerrini G; Ciciani G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Daniele S; Martini C; Ghelardini C; Norcini M; Ciattini S; Costanzo A
J Med Chem; 2010 Nov; 53(21):7532-48. PubMed ID: 20939501
[TBL] [Abstract][Full Text] [Related]
9. Novel 3-aroylpyrazolo[5,1-c][1,2,4]benzotriazine 5-oxides 8-substituted, ligands at GABAA/benzodiazepine receptor complex: synthesis, pharmacological and molecular modeling studies.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
Bioorg Med Chem; 2008 Apr; 16(8):4471-89. PubMed ID: 18325771
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.
Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM
Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950
[TBL] [Abstract][Full Text] [Related]
11. High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives.
Primofiore G; Da Settimo F; Taliani S; Salerno S; Novellino E; Greco G; Cosimelli B; Besnard F; Costa B; Montali M; Martini C
J Med Chem; 2005 Apr; 48(8):2936-43. PubMed ID: 15828832
[TBL] [Abstract][Full Text] [Related]
12. A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABA
Guerrini G; Ciciani G; Daniele S; Martini C; Costagli C; Guarino C; Selleri S
Bioorg Med Chem; 2018 May; 26(9):2475-2487. PubMed ID: 29650463
[TBL] [Abstract][Full Text] [Related]
13. Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor.
Hintermann S; Hurth K; Nozulak J; Tintelnot-Blomley M; Aichholz R; Blanz J; Kaupmann K; Mosbacher J
Bioorg Med Chem Lett; 2011 Mar; 21(5):1523-6. PubMed ID: 21277199
[TBL] [Abstract][Full Text] [Related]
14. Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Goodacre SC; Hallett DJ; Carling RW; Castro JL; Reynolds DS; Pike A; Wafford KA; Newman R; Atack JR; Street LJ
Bioorg Med Chem Lett; 2006 Mar; 16(6):1582-5. PubMed ID: 16384707
[TBL] [Abstract][Full Text] [Related]
15. Studies of molecular pharmacophore/receptor models for GABAA/BzR subtypes: binding affinities of symmetrically substituted pyrazolo[4,3-c]quinolin-3-ones at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
He X; Huang Q; Yu S; Ma C; McKernan R; Cook JM
Drug Des Discov; 1999 Jul; 16(1):77-91. PubMed ID: 10466058
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
J Med Chem; 2009 Aug; 52(15):4668-82. PubMed ID: 19591485
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 2-[3,5-substituted pyrazol-1-yl]-4,6-trisubstituted triazine derivatives as antimalarial agents.
Katiyar SB; Srivastava K; Puri SK; Chauhan PM
Bioorg Med Chem Lett; 2005 Nov; 15(22):4957-60. PubMed ID: 16168643
[TBL] [Abstract][Full Text] [Related]
18. Discovery of functionally selective 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABA A receptor agonists at the alpha3 subunit.
Russell MG; Carling RW; Atack JR; Bromidge FA; Cook SM; Hunt P; Isted C; Lucas M; McKernan RM; Mitchinson A; Moore KW; Narquizian R; Macaulay AJ; Thomas D; Thompson SA; Wafford KA; Castro JL
J Med Chem; 2005 Mar; 48(5):1367-83. PubMed ID: 15743180
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site.
Street LJ; Sternfeld F; Jelley RA; Reeve AJ; Carling RW; Moore KW; McKernan RM; Sohal B; Cook S; Pike A; Dawson GR; Bromidge FA; Wafford KA; Seabrook GR; Thompson SA; Marshall G; Pillai GV; Castro JL; Atack JR; MacLeod AM
J Med Chem; 2004 Jul; 47(14):3642-57. PubMed ID: 15214791
[TBL] [Abstract][Full Text] [Related]
20. The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated.
Atack JR; Bayley PJ; Fletcher SR; McKernan RM; Wafford KA; Dawson GR
Eur J Pharmacol; 2006 Oct; 548(1-3):77-82. PubMed ID: 16962577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
